Silexion Therapeutics Corp share price logo

Silexion Therapeutics Corp Share Price

NASDAQ: SLXN

Small Cap

$3.33

-0.21

(-5.93%)

as on

Silexion Therapeutics Corp Stock Performance

as on October 23, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.3
    $3.51
    downward going graph

    0.90%

    Downside

    5.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.25
    $63.45
    downward going graph

    2.40%

    Downside

    1805.41%

    Upside

    downward going graph

Silexion Therapeutics Corp share price movements today

Previous Close
$3.54
Open
$3.50
Volume
755.2K
Day's Low - High
$3.3 - $3.51
52 Week Low - High
$3.25 - $63.45

Silexion Therapeutics Corp Historical Returns

1 Month Return
-2.48 %
3 Month Return
-72.07 %
1 Year Return
-94.17 %
3 Year Return
0 %
5 Year Return
0 %

Silexion Therapeutics Corp Stock Fundamentals & Key Indicators

Check Silexion Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.4M

EPS (TTM)

-12.06

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

219210600.00%

Silexion Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silexion Therapeutics Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Silexion Therapeutics Corp image
Silexion Therapeutics Corp
NA$11.4MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$64.4B252.94%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.3BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$107.5B102.91%29.6831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$61.3B0.63%14.5831.37%

Stock Returns calculator for Silexion Therapeutics Corp Stock including INR - Dollar returns

The Silexion Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Silexion Therapeutics Corp investment value today

Current value as on today

₹10,040

Returns

₹89,960

(-89.96%)

Returns from Silexion Therapeutics Corp Stock

₹94,518 (-94.52%)

Dollar Returns*

₹4,557 (+4.56%)

Silexion Therapeutics Corp Stock’s Investor Sentiment and Interest

Search interest for Silexion Therapeutics Corp Stock has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-83% versus previous 30 day period

Silexion Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
0
-
0
0
Operating Income
0
0
0
-1
-1
-1
-8
-1
-1
-2
EBITDA
0
0
0
-1
-1
-1
-8
-5
-1
-2
Interest Expense
-
0
-
0
-
0
0
-
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
-1
-1
-1
-11
-1
-1
-2
Income Tax Expense
0
-
0
0
0
0
0
0
-
0
Net Income
0
0
0
-1
-1
-1
-11
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Silexion Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
-
-
0
Operating Income
-3
-4
-12
EBITDA
-3
-4
-16
Interest Expense
0
0
0
Depreciation
0
0
0
Income Before Tax
-3
-5
-16
Income Tax Expense
0
0
0
Net Income
-3
-4
16
Net Profit Margin
0.00%
0.00%
0.00%

Silexion Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
0
0
-1
-1
-1
-11
-1
-1
-2
Operating Cash Flow
0
0
-1
-1
-1
-2
-2
-2
-2
Investing Cash Flow
-
0
0
0
-
0
-
0
0
Financing Cash Flow
0
-
-
-
-
2
2
7
0
Change in Cash
0
0
-1
-1
-1
0
0
4
-2

Silexion Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
0
0
-3
-5
-16
Operating Cash Flow
0
-1
-3
-4
-8
Investing Cash Flow
-
-
0
0
0
Financing Cash Flow
0
116
2
0
5
Change in Cash
0
0
-1
-3
-3

Insights on Silexion Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.7% return, outperforming this stock by 152.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, SLXN stock has moved down by -73.2%

About Silexion Therapeutics Corp

Silexion Therapeutics Corp is an oncology-focused biotechnology company. The Company is engaged in the development of treatments for unsatisfactorily treated solid tumor cancers, which have the mutated KRAS oncogene. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals to the cell nucleus. Based on its research of refractory solid tumor cancers, it is developing a platform focused on the silencing of the KRAS oncogene using ribonucleic acid (RNA)-interference therapeutics. Its lead product candidate, SIL-204B, consists of locally administered small interfering RNAs (siRNA), in an extended-release formulation, as a first-line treatment of locally advanced pancreatic cancer patients, in combination with standard-of-care chemotherapy. Its clinical-stage pipeline is focused on treatment for pancreatic cancer (PC) tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected.
OrganisationSilexion Therapeutics Corp
HeadquartersThe Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
CEOMr. Ilan Hadar M.B.A.
E-voting on sharesClick here to vote

Key Management of Silexion Therapeutics Corp

Name

Title

Mr. Ilan Hadar M.B.A.

Chairman & CEO

Ms. Mirit Horenshtein Hadar

EVP of Finance Affairs, CFO & Secretary

Dr. Mitchell Shirvan M.B.A., Ph.D.

Chief Scientific & Development Officer

FAQs

What is Silexion Therapeutics Corp share price today?

Silexion Therapeutics Corp share price today is $3.33 as on at the close of the market. Silexion Therapeutics Corp share today touched a day high of $3.51 and a low of $3.3.

What is the 52 week high and 52 week low for Silexion Therapeutics Corp share?

Silexion Therapeutics Corp share touched a 52 week high of $63.45 on and a 52 week low of $3.25 on . Silexion Therapeutics Corp stock price today i.e. is closed at $3.33,which is 94.75% down from its 52 week high and 2.46% up from its 52 week low.

What is Silexion Therapeutics Corp's market capitalisation today?

Silexion Therapeutics Corp market capitalisation is $0.00T as on .

How to invest in Silexion Therapeutics Corp Stock (SLXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Silexion Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion Therapeutics Corp Shares that will get you 0.4505 shares as per Silexion Therapeutics Corp share price of $3.33 per share as on October 23, 2025 at 1:29 am IST.

What is the minimum amount required to buy Silexion Therapeutics Corp Stock (SLXN) from India?

Indian investors can start investing in Silexion Therapeutics Corp (SLXN) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Silexion Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Silexion Therapeutics Corp share’s latest price of $3.33 as on October 23, 2025 at 1:29 am IST, you will get 3.0030 shares of Silexion Therapeutics Corp. Learn more about fractional shares .